Research Repository

Triadic Citations, Country Biases and Patent Value: The Case of Pharmaceuticals

Messinis, George (2011) Triadic Citations, Country Biases and Patent Value: The Case of Pharmaceuticals. Scientometrics, 89 (3). pp. 818-833. ISSN 0138-9130

Full text for this resource is not available from the Research Repository.

Abstract

Triadic patents minimise home bias effects in studies that focus on patent counts as a measure of innovative activity. Yet, biases in qualitative patent indicators have been largely neglected. This article advocates that forward patent citations, and triadic citations in particular, can illuminate further on home bias, self citations, and the speed of knowledge flows for drug patents published by the USPTO for the period 1980–2008. The evidence shows that triadic citations help to minimize the home bias in citations as well as to make patent quality more transparent. Also, it indicates that self citations and the age distribution of citations are important factors to consider when explaining cross-country differences in pharmaceutical citations.

Item Type: Article
Uncontrolled Keywords: ResPubID24433, patents, triadic citations, self-citations, pharmaceuticals, OECD countries, biases
Subjects: FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
FOR Classification > 1402 Applied Economics
SEO Classification > 970114 Expanding Knowledge in Economics
Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
Depositing User: VUIR
Date Deposited: 27 Sep 2012 02:05
Last Modified: 03 May 2018 07:46
URI: http://vuir.vu.edu.au/id/eprint/9448
DOI: https://doi.org/10.1007/s11192-011-0473-z
ePrint Statistics: View download statistics for this item
Citations in Scopus: 12 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar